CClinicalTrials.gg
CompletedNCT05571384Updated Dec 5, 2025

High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes

An interventional study of high intensity body-weight circuit in Type2diabetes, sponsored by Kennesaw State University. Completed at 1 site in United States. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by Kennesaw State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Not applicable
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This research study proposes to quantify the efficacy of the novel high intensity body-weight circuit (HIBC) training intervention on metabolic profile, body composition, and health related fitness exercise in middle aged persons with type-2 diabetes (T2DM). This research project is extremely relevant to public health, in that prevalence of T2DM continues to rise on a national and global scale, placing a heavy economic cost on both the healthcare industry and the individual patient in an age-dependent fashion. Results of this study may provide an effective and appealing alternative exercise intervention for cardiometabolic disease management in adults with T2DM, and have significant clinical and public health applications.

02

Conditions studied

  • Type2diabetes

Browse trials for

Keywords

  • Exercise
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 22 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Kennesaw State University is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Recent diagnosed of type 2 diabetes (T2DM) (within a year) * HbA1c of 6% or higher

    • Non-insulin dependent
    • No medicinal treatment
    • Not currently undergoing a physical activity program in the last six months
    • Received written medical clearance from overseeing physician

Exclusion criteria

Exclusion Criteria:

  • Those who have undergone any revascularization procedure

    • Diagnosed with or symptomatic of any renal, pulmonary, or cardiovascular disease (CVD)
    • Diagnosed cognitive dysfunction
    • Current smoker
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    high intensity body-weight circuit (HIBC)

    HIBC Exercise Protocol- circuit repetition and order is as follows: modified squats (10 repetitions), modified rows (5 repetitions), crunches (10), and modified push-ups (5). The exercise sessions will involve repeating a series of repetitions of each movement in sequence, and completing as many sequences as possible in good form in the time allotted for the exercise (initially, 5 minutes). Three sessions per week will be completed at home. After three weeks of training, participants will be asked to add a fourth session each week. Initially, the HIBC sessions will be five minutes long, and the duration of the sessions will increase by one minute each week as tolerated beginning in week four, peaking at 10-minutes per session (warm up not included in this timing) as early as the eighth week of training. Session duration will be capped at 10-minutes.

    Behavioral: high intensity body-weight circuit

Interventions

  • Behavioralhigh intensity body-weight circuit

    Bodyweight and suspension training equipment (TRX® Fit System) with modified movements. Modified Squats: participants will be instructed to hold the handles of the band with arms extended, participants will then lean back in a standing position and perform a squat within a comfortable range of motion while weight is being distributed to the band. Modified Rows: participants will grab the bands with arms and legs extended. They will find a comfortable angle by which to perform a "row" (pulling the handles to the rib cage) with arms at a 45-degree angle. Modified Push-Ups: perform push-ups on their knees with a flat back and hands underneath their shoulders. They will be instructed to lower their chest towards the ground in a controlled manner and as far as comfort will allow them. Modified Crunches: participants will lay on their back with feet approximately 8-10 inches from their buttocks, and asked to lift their shoulders slightly off the ground.

06

What researchers measure

Primary outcomes

  1. HbA1c change within participant

    HbA1c (glycosylated Hemoglobin) indicates what the blood glucose environment was like for that past 3-months. This is the average life span of a red blood cell. High levels of blood glucose over a 3 month period lead to high HbA1c and vis versa. HbA1c can change as early as 14 weeks.

    Time frame: Pre and post 16-week intervention

  2. Oral Glucose Tolerance Test change within participant

    Glucose and Insulin response to bolus amount of glucose beverage

    Time frame: Pre and post 16-week intervention

  3. Body Composition change within participant

    Fat mass and lean mass

    Time frame: Pre and post 16-week intervention

  4. Estimated VO2max (oxygen consumption), aerobic exercise capacity change within participant

    sub maximal treadmill endurance test

    Time frame: Pre and post 16-week intervention

07

Study locations

1 site
  • Kennesaw State Univeristy
    Kennesaw, Georgia 30144, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05571384
Lead sponsor
Kennesaw State University
Responsible party
Brian Kliszczewicz (Associate Professor, Kennesaw State University) — Principal investigator
First posted
Oct 7, 2022
Start date
Jul 26, 2022
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Last update
Dec 5, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion